ADIAL PHARMACEUTICALS, INC. (52)
Browse by Contract Category
Contracts
-
Amendment No. 4 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan
(Filed With SEC on October 13, 2022)
-
Placement Agency Agreement
(Filed With SEC on February 14, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on February 14, 2022)
-
Lockup Agreement Extension executed Dr. Bankole Johnson, dated April 5, 2021
(Filed With SEC on April 9, 2021)
-
Amendment 7 to License Agreement by and between the University of Virginia Patent Foundation d/b/a the University of Virginia Licensing and Ventures Group and Adial...
(Filed With SEC on December 31, 2019)
-
Amendment, dated September 8, 2022, to Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole A. Johnson, dated March 24, 2019, as amended on March 22, 2022
(Filed With SEC on September 13, 2022)
-
Amendment to Employment Agreement, dated as of August 22, 2022, between Adial Pharmaceuticals, Inc. and William B. Stilley
(Filed With SEC on August 23, 2022)
-
Amendment to Employment Agreement, dated as of August 22, 2022, between Adial Pharmaceuticals, Inc. and Cary J. Claiborne
(Filed With SEC on August 23, 2022)
-
Amendment, dated March 22, 2022, to Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated March 24, 2019
(Filed With SEC on March 28, 2022)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on February 14, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on February 14, 2022)
-
Employment Agreement between Adial Pharmaceuticals, Inc. and Cary Claiborne, dated as of December 7, 2021
(Filed With SEC on December 9, 2021)
-
Form of Stock Purchase Agreement
(Filed With SEC on November 12, 2021)
-
Form of Registration Rights Agreement
(Filed With SEC on November 12, 2021)
-
Amendment No. 3 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan
(Filed With SEC on September 29, 2021)
-
Form of Registration Rights Agreement
(Filed With SEC on July 9, 2021)
-
Form of Stock Purchase Agreement
(Filed With SEC on July 9, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on June 23, 2021)
-
Amendment to Executive Employment Agreement with William B. Stilley, III, effective as of March 17, 2021
(Filed With SEC on March 22, 2021)
-
Amendment to Executive Employment Agreement with Joseph Truluck, effective as of February 12, 2021
(Filed With SEC on March 22, 2021)
-
Amendment to Executive Employment Agreement with William B. Stilley, III, effective as of February 12, 2021
(Filed With SEC on March 22, 2021)
-
Description of Securities
(Filed With SEC on March 22, 2021)
-
Form of Registration Rights Agreement
(Filed With SEC on March 15, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on March 15, 2021)
-
Amendment, dated January 25, 2021, by and among Adial Pharmaceuticals, Inc., Purnovate, Inc., a wholly owned subsidiary of Adial, PNV Conversion Corp. as successor-in interest to...
(Filed With SEC on February 1, 2021)
-
Offer Letter, dated December 14, 2020
(Filed With SEC on December 17, 2020)
-
Equity Purchase Agreement, dated December 7, 2020, by and among Adial Pharmaceuticals, Inc., Purnovate, LLC, the members of Purnovate, LLC and Robert D. Thompson, as member...
(Filed With SEC on December 10, 2020)
-
Registration Rights Agreement, dated as of November 18, 2020, by and between Adial Pharmaceuticals, Inc. and Keystone Capital Partners, LLC
(Filed With SEC on November 24, 2020)
-
Common Stock Purchase Agreement, dated as of November 18, 2020, by and between Adial Pharmaceuticals, Inc. and Keystone Capital Partners, LLC
(Filed With SEC on November 24, 2020)
-
Lock-Up Agreement Extension and Right of First Refusal dated August 19, 2020 to Lock-Up Agreement
(Filed With SEC on August 25, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on June 12, 2020)
-
Form of Securities Purchase Agreement, dated as of June 9, 2020, by and among Adial Pharmaceuticals, Inc. and the Investors
(Filed With SEC on June 10, 2020)
-
Placement Agency Agreement, dated June 9, 2020, by and among Adial Pharmaceuticals, Inc. and Maxim Group LLC and Joseph Gunnar & Co., LLC
(Filed With SEC on June 10, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on June 10, 2020)
-
Description of Securities
(Filed With SEC on March 20, 2020)
-
Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated as of March 3, 2020
(Filed With SEC on March 6, 2020)
-
Amendment to Statement of Work under Master Services Agreement dated December 12, 2019, by and between Adial Pharmaceuticals, Inc. and Psychological Education Publishing Company
(Filed With SEC on December 16, 2019)
-
Guaranty, dated December 12, 2019, executed by Dr. Bankole Johnson
(Filed With SEC on December 16, 2019)
-
Pledge and Security Agreement, dated December 12, 2019
(Filed With SEC on December 16, 2019)
-
Lock-Up Agreement, dated December 12, 2019
(Filed With SEC on December 16, 2019)
-
Master Services Agreement and related statement of work, dated July 5, 2019, by and between Adial Pharmaceuticals, Inc. and Psychological Education Publishing Company
(Filed With SEC on July 8, 2019)
-
Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated March 24, 2019
(Filed With SEC on March 26, 2019)
-
Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and William Stilley, dated as of March 11, 2019
(Filed With SEC on March 14, 2019)
-
Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated as of March 11, 2019
(Filed With SEC on March 14, 2019)
-
Form of Warrant Agency Agreement dated February 25, 2019 between Adial Pharmaceuticals, Inc. and VStock Transfer, LLC
(Filed With SEC on February 26, 2019)
-
Form of Warrant
(Filed With SEC on February 26, 2019)
-
Underwriting Agreement, dated February 21, 2019, by and among Adial Pharmaceuticals, Inc., Maxim Group LLC and Joseph Gunnar & Co., LLC
(Filed With SEC on February 26, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on February 19, 2019)
-
Form of Common Stock Warrant
(Filed With SEC on February 19, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on February 12, 2019)
-
Form of Common Stock Warrant
(Filed With SEC on February 12, 2019)
-
Form of Warrant Agency Agreement
(Filed With SEC on February 12, 2019)